Skip to main content
. 2024 Mar 6;25(5):3049. doi: 10.3390/ijms25053049

Figure 1.

Figure 1

In vitro characterization of F3, F3 ddpR, Brca1−/− and Brca1−/− ddpR cells. Dose–response curves of cisplatin in F3 (blue line) and F3 ddpR (green line) cells (A) and Brca1−/− (pink line) and Brca1−/− ddpR (orange line) cells (B). Data are the mean ± standard deviation (SD) of three independent experiments run in sestuplicate. (C) Colony assay of ID8 F3 and F3 ddpR untreated and after DDP 4 µM, 8 µM, 16 µM, 32 µM and 64 µM. (D) Colony assay of ID8 Brca1−/− and Brca1−/− ddpR untreated and after DDP 2 µM, 4 µM, 8 µM, 16 µM and 32 µM. Magnification 1×.